Phospho-NEUROD1 (Ser274) Antibody

What is NEUROD1 and what role does phosphorylation at Ser274 play in its function?

NEUROD1 (Neurogenic Differentiation Factor 1) is a basic helix-loop-helix (bHLH) transcription factor that plays critical roles in neurogenesis and pancreatic development. NEUROD1 forms heterodimers with other bHLH proteins to activate transcription of genes containing E-box sequences .

The phosphorylation of NEUROD1 at Serine 274 is a post-translational modification that regulates its activity and subcellular localization. In pancreatic β-cells, Ser274 phosphorylation occurs in response to glucose stimulation and is required for proper nuclear localization and activation of target genes, including insulin . This phosphorylation event represents a key regulatory mechanism controlling NEUROD1's transcriptional activity.

What are the typical validated applications for Phospho-NEUROD1 (Ser274) antibodies?

Based on extensive validation data, Phospho-NEUROD1 (Ser274) antibodies have been successfully employed in:

Most commercially available Phospho-NEUROD1 (Ser274) antibodies have been primarily validated for Western blotting applications, with specific recommendations to use HeLa cells as a positive control .

How should I design experiments to verify Phospho-NEUROD1 (Ser274) antibody specificity in my system?

To verify antibody specificity, a multi-pronged approach is recommended:

• Phosphatase treatment control: Treat half of your sample with lambda phosphatase before Western blotting. The signal should disappear in the treated sample if the antibody is phospho-specific.

• Peptide competition assay: Pre-incubate the antibody with excess phospho-peptide (P-L-S(p)-P-P) and non-phospho-peptide. Signal should be blocked by the phospho-peptide but not by the non-phospho-peptide .

• Genetic validation: Use NEUROD1 knockout/knockdown samples as negative controls, and samples with modulated kinase activity to alter phosphorylation levels.

• Molecular weight confirmation: Verify that the detected band appears at approximately 36 kDa, the expected molecular weight for NEUROD1 .

Remember that specificity validation should be performed in your specific experimental system, as phosphorylation patterns may vary across cell types and conditions.

What are the optimal sample preparation methods for detecting phosphorylated NEUROD1?

To effectively preserve and detect phosphorylated NEUROD1:

• Lysis buffer composition: Use a phosphatase inhibitor-enriched buffer containing:

  • 50 mM Tris-HCl (pH 7.4)

  • 150 mM NaCl

  • 1% NP-40 or Triton X-100

  • 1 mM EDTA

  • Phosphatase inhibitor cocktail (critical)

  • Protease inhibitor cocktail

  • 1 mM sodium orthovanadate

  • 5 mM sodium fluoride

• Sample handling: Maintain samples at 4°C throughout processing to minimize phosphatase activity.

• Protein denaturation: Heat samples at 95°C for only 5 minutes to prevent phosphate group hydrolysis.

• Gel electrophoresis: Use freshly prepared SDS-PAGE gels (10-12%) for optimal separation around the 36 kDa range where NEUROD1 migrates .

How can Phospho-NEUROD1 (Ser274) antibodies be used to study the molecular mechanisms of insulin gene regulation?

Phospho-NEUROD1 (Ser274) antibodies have been instrumental in elucidating the glucose-responsive transcriptional complex that regulates insulin gene expression. Research strategies include:

• Chromatin immunoprecipitation (ChIP): Use the phospho-specific antibody to determine if Ser274 phosphorylation alters NEUROD1 binding to the insulin gene promoter, particularly at E-box elements.

• Co-immunoprecipitation studies: Investigate how Ser274 phosphorylation affects NEUROD1's interaction with other transcription factors like Pdx1, which has been shown to synergistically activate insulin gene transcription with NEUROD1 .

• Glucose stimulation experiments: Compare the kinetics of NEUROD1 phosphorylation at Ser274 with insulin gene expression following glucose stimulation of pancreatic β-cells.

• Kinase identification assays: Couple phospho-antibody detection with kinase inhibitor treatments to identify the specific kinase responsible for Ser274 phosphorylation in different cellular contexts.

Research has shown that NEUROD1 and Pdx1 physically interact in the nucleus and synergistically activate the insulin gene promoter, with FRET analysis demonstrating a direct interaction with 24.8% FRET efficiency .

What are the most effective approaches for analyzing NEUROD1 phosphorylation dynamics in neurogenesis studies?

For studying phosphorylation dynamics in neurogenesis:

• Time-course immunofluorescence analysis: Combine Phospho-NEUROD1 (Ser274) antibody with markers of neuronal differentiation stages to track when phosphorylation occurs during development.

• Phospho-specific flow cytometry: Quantitatively measure phosphorylation levels in neuronal progenitor populations at different differentiation stages.

• Phosphoproteomic analysis: Complement antibody-based detection with mass spectrometry to identify multiple phosphorylation sites on NEUROD1 and their relative abundance during neurogenesis.

• In vivo models: Use phospho-specific antibodies in developmental studies of the central nervous system to identify spatial and temporal patterns of NEUROD1 phosphorylation.

Recent studies have employed these approaches to demonstrate that NEUROD1 phosphorylation states correlate with specific stages of neuronal differentiation and dendrite morphogenesis .

What are common pitfalls when using Phospho-NEUROD1 (Ser274) antibodies and how can they be addressed?

Common challenges and their solutions include:

Additional considerations:

• Blocking with 5% BSA instead of milk is generally more effective for phospho-specific antibodies

• Overnight primary antibody incubation at 4°C typically yields better results than shorter incubations at room temperature

How should researchers interpret conflicting results between total NEUROD1 and phospho-specific antibody signals?

When faced with discrepancies between total and phospho-specific NEUROD1 antibody signals, consider these analytical approaches:

• Ratio analysis: Calculate the phospho-NEUROD1/total NEUROD1 ratio to normalize for expression differences. This helps distinguish between changes in phosphorylation state versus changes in total protein levels.

• Subcellular fractionation: Analyze nuclear versus cytoplasmic fractions separately, as Ser274 phosphorylation affects NEUROD1's nuclear localization.

• Dephosphorylation controls: Treat samples with lambda phosphatase to confirm that the phospho-antibody signal is truly phosphorylation-dependent.

• Biological context: Consider the physiological state of your samples. In pancreatic β-cells, glucose stimulation should increase Ser274 phosphorylation, while in neurons, activity-dependent signaling may regulate phosphorylation .

Remember that total protein levels and phosphorylation levels may not change in parallel, as post-translational modifications often occur independently of expression changes.

How does NEUROD1 Ser274 phosphorylation contribute to diabetes pathophysiology and potential therapeutic approaches?

NEUROD1 phosphorylation at Ser274 represents a critical regulatory node in pancreatic β-cell function:

• Pathophysiological relevance: Mutations in NEUROD1 cause Maturity Onset Diabetes of the Young type 6 (MODY6), and altered phosphorylation may contribute to β-cell dysfunction in type 2 diabetes .

• Signaling integration: Ser274 phosphorylation connects glucose sensing mechanisms to transcriptional activation of the insulin gene through the NEUROD1-Pdx1 complex.

• Therapeutic targeting: Small molecules that modulate NEUROD1 phosphorylation or mimic its phosphorylated state could represent novel approaches for enhancing insulin production in diabetic patients.

• Stem cell applications: Monitoring Ser274 phosphorylation during directed differentiation of pluripotent stem cells into β-cells could serve as a quality control measure for regenerative medicine approaches to diabetes .

Recent research indicates that NEUROD1 phosphorylation states could be manipulated to enhance β-cell function or survival under diabetic stress conditions.

What are emerging applications of Phospho-NEUROD1 (Ser274) antibodies in cancer and neurodegenerative disease research?

Emerging research areas include:

• Medulloblastoma research: NEUROD1 has been implicated in medulloblastoma tumorigenesis, with phosphorylation potentially regulating its oncogenic properties. Phospho-NEUROD1 antibodies can help stratify tumors based on NEUROD1 activation state .

• Neurodegenerative diseases: Altered phosphorylation of transcription factors is increasingly recognized in conditions like Alzheimer's and Parkinson's diseases. Phospho-NEUROD1 analysis may reveal dysregulated neuronal differentiation or maintenance mechanisms.

• Single-cell phosphoproteomic analysis: Combining phospho-specific antibodies with single-cell technologies enables mapping of NEUROD1 activation states across heterogeneous cell populations in complex tissues.

• Blood-based biomarkers: Detecting phosphorylated NEUROD1 in circulating extracellular vesicles might serve as a biomarker for pancreatic or neural tissue pathology.

These emerging applications highlight the increasing importance of phosphorylation-specific analyses in understanding disease mechanisms and developing targeted therapies.

How can CRISPR-based approaches be combined with Phospho-NEUROD1 (Ser274) antibodies to advance functional studies?

Integrating CRISPR technology with phospho-specific antibody detection enables sophisticated functional studies:

• CRISPR knock-in of phosphomimetic mutants: Replace Ser274 with glutamic acid (S274E) to mimic constitutive phosphorylation or with alanine (S274A) to prevent phosphorylation, then assess functional outcomes.

• Activation domain fusions: Create CRISPR activator systems targeting kinases that phosphorylate Ser274, then monitor changes using phospho-specific antibodies.

• Live-cell phosphorylation sensors: Develop CRISPR knock-in constructs that incorporate fluorescent reporters around the Ser274 site to create biosensors that change conformation upon phosphorylation.

• Temporal control systems: Combine optogenetic or chemically-inducible kinase systems with phospho-antibody detection to precisely map the kinetics of NEUROD1 activation and downstream effects.

These approaches enable direct manipulation of the phosphorylation state while monitoring outcomes with phospho-specific antibodies, providing powerful tools for dissecting signaling pathways.

What are optimal strategies for multiplexed detection of NEUROD1 phosphorylation in relation to other post-translational modifications?

For comprehensive post-translational modification (PTM) analysis:

• Sequential immunoprecipitation: First immunoprecipitate with Phospho-NEUROD1 (Ser274) antibody, then probe the immunoprecipitate for other modifications (acetylation, ubiquitination, other phosphorylation sites).

• Multiplexed immunofluorescence: Combine Phospho-NEUROD1 (Ser274) antibody with antibodies against other PTMs using spectral unmixing microscopy to visualize multiple modifications simultaneously.

• Mass spectrometry validation: Use antibody-based enrichment followed by mass spectrometry to identify co-occurring modifications on the same NEUROD1 molecule.

• Proximity ligation assays: Detect spatial relationships between Ser274 phosphorylation and other modifications using antibody pairs and rolling circle amplification.

Recent studies suggest that Ser274 phosphorylation may interact with other modifications on NEUROD1 to create a complex regulatory code that fine-tunes its transcriptional activity in different cellular contexts .